Quality of benzathine penicillin G: A multinational cross‐sectional study

Benzathine penicillin G (BPG) is used as first‐line treatment for most forms of syphilis and as secondary prophylaxis against rheumatic heart disease (RHD). Perceptions that poor quality of BPG is linked to reported adverse effects and therapeutic failure may impact syphilis and RHD control programs...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Pharmacol Res Perspect
Päätekijät: Hand, Robert M., Senarathna, S. M. D. K. Ganga, Page‐Sharp, Madhu, Gray, Katherine, Sika‐Paotonu, Dianne, Sheel, Meru, Chuang, Victor T. G., Martinez, Jorge, Luna, Giuseppe, Manning, Laurens, Wyber, Rosemary, Carapetis, Jonathan R., Batty, Kevin T.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley and Sons Inc. 2020
Aiheet:
Original Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7580708/
https://ncbi.nlm.nih.gov/pubmed/33090729
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/prp2.668
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia